KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bausch Health Companies (BHC) Restructuring Costs (2016 - 2024)

Bausch Health Companies' Restructuring Costs history spans 16 years, with the latest figure at -$2.0 million for Q4 2024.

  • On a quarterly basis, Restructuring Costs rose 33.33% to -$2.0 million in Q4 2024 year-over-year; TTM through Mar 2026 was -$2.0 million, a N/A change, with the full-year FY2022 number at $33.0 million, up 3.12% from a year prior.
  • Restructuring Costs hit -$2.0 million in Q4 2024 for Bausch Health Companies, down from $2.0 million in the prior quarter.
  • Over the last five years, Restructuring Costs for BHC hit a ceiling of $13.0 million in Q2 2022 and a floor of -$3.0 million in Q4 2023.
  • Historically, Restructuring Costs has averaged $5.4 million across 5 years, with a median of $5.0 million in 2021.
  • Biggest five-year swings in Restructuring Costs: surged 233.33% in 2020 and later tumbled 200.0% in 2023.
  • Tracing BHC's Restructuring Costs over 5 years: stood at $10.0 million in 2020, then increased by 20.0% to $12.0 million in 2021, then crashed by 75.0% to $3.0 million in 2022, then tumbled by 200.0% to -$3.0 million in 2023, then soared by 33.33% to -$2.0 million in 2024.
  • Business Quant data shows Restructuring Costs for BHC at -$2.0 million in Q4 2024, $2.0 million in Q3 2024, and -$3.0 million in Q4 2023.